TMO
NYSE · Life Sciences Tools & Services
Thermo Fisher Scientific Inc
$588.29
-7.60 (-1.28%)
TMO News17 articles
XLV Retreats from Record as Mid-Sized Health Care Names Lag
XLV hit a record $169.71 before closing lower, lagging the S&P 500 by 0.74 points. Weakness among smaller health care holdings offset gains in top components.
Avantor Surges 15% on Sales Beat, but Margin Concerns Persist
Avantor (AVTR) shares surged 15% after Q2 results beat estimates, but margin and cash-flow targets remained unchanged, signaling a demand reset.
Danaher's 50% Rebound Faces $100M Bioprocessing Deferral Hurdle
Danaher shares rebounded 50% from a post-earnings drop, but a $100 million bioprocessing revenue delay to 2027 tests the recovery.
Megacap Cash Burn and Surging Oil Pressure Markets
U.S. stocks fell sharply on Thursday, led by a 2.3% drop in the Nasdaq, after Alphabet and Tesla reported heavy capital spending and negative free cash flow. Brent crude surged above $101, adding to inflation fears ahead of the Fed meeting.
Thermo Fisher Stock Surges on Strong Instrument Profit Growth
Thermo Fisher shares rose roughly 10% after Q2 revenue beat estimates and the company boosted its profit outlook, driven by strong margin expansion in Analytical Instruments.
Danaher Plunges 11% as Biotech Growth Disappoints, Triggering Valuation Reset
Danaher shares dropped 11% after its biotech segment underperformed expectations, leading to a valuation adjustment. Full-year core growth guidance was narrowed to 3%-4%.
Danaher Tumbles 11% as Biotech Growth Disappoints, Triggering Valuation Reset
Danaher shares plunged 11% on Tuesday after biotech growth fell short of expectations, prompting a sharp valuation reset even as quarterly revenue and earnings topped forecasts.
Danaher Shares Plunge 14% on Reduced Growth Forecast and Bioprocessing Gap
Danaher (DHR) stock dropped 14% after the company slashed its 2026 core-revenue growth forecast to 3%-4%, citing a bioprocessing order-to-revenue gap that overshadowed a quarterly earnings beat.
10x Genomics Tumbles on Revenue Slide; Buffett Warns of 'Gambling Mood'
10x Genomics shares dropped 5.3% after Q1 revenue fell 2.6% year-over-year, while Warren Buffett cautioned investors against a 'gambling mood' driving unsustainable valuations.
Market Update: Tech Rotation, Mining Surges, and Valuation Gaps
Markets on April 12, 2026, saw a notable rotation out of technology, creating opportunities in stocks like Nvidia and Alphabet. Meanwhile, Futu Holdings rallied but trades below intrinsic value, and G Mining Ventures soared despite valuation disparities.
Markets Plunge on Geopolitical Fears, Nifty Tests Key Support
Indian equity indices tumbled sharply at Monday's open, with the Sensex shedding over 1,650 points, as escalating Middle East tensions and a spike in crude oil above $110 spooked investors.
Thermo Fisher Shares Extend Slide Amid Clario Acquisition Financing
Thermo Fisher Scientific shares declined 0.98% to $504.82 on Friday, extending a recent downturn. The company has raised $3.8 billion in senior notes to partially fund its acquisition of clinical data firm Clario.
Thermo Fisher Prices $3.8B Bond Offering to Fund Clario Acquisition
Thermo Fisher Scientific raised $3.8 billion through a multi-tranche bond offering to fund its planned Clario acquisition. Shares closed down nearly 1% on Friday.
Danaher Shares Slip Ahead of Holiday, Traders Eye PCE Data
Danaher shares fell in extended trading Friday, closing near $212.58. The dip precedes a market holiday, with attention shifting to next week's key inflation report.
Thermo Fisher Files Multi-Tranche Bond Offering to Finance Clario Acquisition
Thermo Fisher Scientific shares edged higher Monday after filing a preliminary prospectus for a four-part senior notes offering to fund its planned Clario acquisition. The company reported consolidated debt of $39.38 billion as of December 31, 2025.
Thermo Fisher Shares End Week Lower Amid Research Funding Concerns
Thermo Fisher Scientific closed Friday at $542.83, down 6.7% for the week as investors weigh pressure from academic research funding cuts. The company's 2026 outlook projects adjusted earnings of $24.22 to $24.80 per share.
Thermo Fisher Shares Stabilize After 4% Drop as Plant Closure and Macro Data Loom
Thermo Fisher Scientific's stock held near $543 Friday following a sharp decline. The company plans to close a Massachusetts facility by 2026, affecting 80 jobs, while investors await key U.S. economic reports.